Takeda Pharmaceutical Li...

NYSE: TAK · Real-Time Price · USD
14.97
0.17 (1.15%)
At close: Aug 15, 2025, 9:58 AM

Takeda Pharmaceutical Balance Sheet Statement

Financials in JPY. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Cash & Equivalents
385.11B 457.8B 533.53B 849.7B
Short-Term Investments
n/a 15.09B 20.17B 25.3B
Long-Term Investments
10.8B 430.61B 378.86B 330.13B
Other Long-Term Assets
792.15B 51.21B 63.33B 82.61B
Receivables
709.47B 697.61B 681.69B 724.38B
Inventory
1,217.3B 1,209.9B 986.46B 853.17B
Other Current Assets
209.26B 193.3B 302.54B 273.26B
Total Current Assets
2,521.2B 2,558.6B 2,398B 2,593.6B
Property-Plant & Equipment
1,968.2B 1,989.8B 1,691.2B 1,582.8B
Goodwill & Intangibles
8,956B 9,684.7B 9,060.4B 8,226.3B
Total Long-Term Assets
11,727.2B 12,550.2B 11,559.8B 10,584.4B
Total Assets
14,248.3B 15,108.8B 13,957.8B 13,178B
Account Payables
475.54B 319.95B 307.45B 295.93B
Deferred Revenue
n/a n/a 740.74B 644.42B
Short-Term Debt
548.94B 367.25B 339.6B 203.99B
Other Current Liabilities
1,482B 1,516B 1,775.3B 1,591.9B
Total Current Liabilities
2,506.5B 2,313.1B 2,481.9B 2,145.7B
Long-Term Debt
3,966.3B 4,476.5B 4,042.7B 4,141.4B
Other Long-Term Liabilities
288.62B 377.98B 179.93B 124.8B
Total Long-Term Liabilities
4,805.8B 5,521.7B 5,121.1B 5,348.8B
Total Liabilities
7,312.4B 7,834.8B 7,603.1B 7,494.5B
Total Debt
5,066.2B 4,843.8B 4,382.3B 4,345.4B
Common Stock
1,694.7B 1,676.6B 1,676.3B 1,676.3B
Retained Earnings
1,187.6B 1,391.2B 1,541.1B 1,479.7B
Comprehensive Income
2,351.9B 2,509.3B 1,508.1B 934.17B
Shareholders Equity
6,935.1B 7,273.3B 6,354.1B 5,683B
Total Investments
10.8B 445.7B 99.17B 96.58B